PACTR201705002221230招募中未知
Terlipressin Infusion for Management of Post-CABG Refractory Hypotension: A Comparative Study versus Nor-epinephrine Infusion
Ahmed Mostafa El-Shaarawy0 个研究点目标入组 44 人开始时间: 2017年4月21日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Year(s) 至 70 Year(s)（—）
- 性别
- All
入选标准
- •Diabetic patients
- •Undergoing elective CABG surgery using CPB
- •Normal ventricular function
- •Experience refractory hypotension after CPB
排除标准
- •Emergency cardiopulmonary bypass
- •Pripheral vascular disease
- •Hepatic or Kidney dysfunction
- •preoperative unstable conditions such as severe arrhythmia, heart failure or cardiogenic shock
研究者
相似试验
已完成
不适用
Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with ARBs undergoing CABGCirculatory Systemvasoplegic syndrome, coronary artery bypass graft surgeryPACTR201804003249274Ain Shams University Hospitals100
已完成
2 期
Outpatient Terlipressin Infusion for the Treatment of Refractory Ascites.AscitesPortal HypertensionDiuretic refractory ascitesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonCirrhosisACTRN12616000321448Paul Gow5
已完成
不适用
Terlipressin infusion in Living Donor Liver TransplantatioPACTR201402000752252ational Liver Institute, Menoufiya University50
已完成
不适用
Terlipressin in liver failureCTRI/2019/10/021737o sponsor required116
进行中（未招募）
1 期
Terlipressin in the treatment of catecholamine-resistant septic shock - Terlipressin in septic shockEUCTR2007-000513-12-CZÚrazová nemocnice brno40